HR 85
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2026-02-12
Current Status:
In Progress
(2026-02-19: Coauthors revised.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
WHEREAS, Angelman syndrome is a rare neurogenetic disorder that occurs in 1 in 15,000 live births and affects approximately 500,000 individuals worldwide; and
WHEREAS, Angelman syndrome is caused by a loss of function of the UBE3A gene in chromosome 15 derived from the mother, and a gene that is needed to develop and control speech and movement; and
WHEREAS, Individuals with Angelman syndrome begin experiencing developmental delays starting from 6 and 12 months of age, inclusive, and these developmental delays are often the first signs of Angelman syndrome; and
WHEREAS, In addition to delayed development, Angelman syndrome causes problems with speech and balance, mental disability, and sometimes seizures; and
WHEREAS, Angelman syndrome shares symptoms and characteristics with other disorders, including autism, cerebral palsy, and Prader-Willi syndrome; and
WHEREAS, Individuals with Angelman syndrome have an overall happy and excitable demeanor, and they smile and laugh often; and
WHEREAS, Angelman syndrome is rare. Most individuals with Angelman syndrome do not have a family history of the syndrome, and researchers often do not know what causes the genetic changes that result in the disease; and
WHEREAS, Angelman syndrome can lead to several complications, including trouble feeding, hyperactivity, sleep troubles, scoliosis, and obesity; and
WHEREAS, The treatment of Angelman syndrome focuses on managing medical, sleep, and developmental issues; and
WHEREAS, There is currently no cure for Angelman syndrome, but organizations such as the Angelman Syndrome Foundation note that with further research, there may be a cure in the future; and
WHEREAS, Organizations worldwide recognize February 15 as International Angelman Day to raise awareness about Angelman syndrome; now, therefore, be it
Resolved by the Assembly of the State of California, That the Assembly hereby recognizes February 15, 2026, as Angelman Syndrome Awareness Day; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Feb 19, 2026 | Coauthors revised. |
| Feb 19, 2026 | Read. Adopted. (Ayes 69. Noes 0. Page 4035.). |
| Feb 17, 2026 | From committee: Be adopted. To Consent Calendar. (Ayes 6. Noes 0.) (February 17). |
| Feb 17, 2026 | Referred to Com. on RLS. |
| Feb 12, 2026 | Introduced. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Feb 19, 2026 | HR 85 Nguyen Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Feb 17, 2026 | Be adopted. To Consent Calendar. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: February 17, 2026
ASSEMBLY COMMITTEE ON RULES
Blanca Pacheco, Chair
ABPCA Bill Id:HR 85 (
Author:Nguyen) – As Introduced Ver:February 12, 2026
SUBJECT: Angelman Syndrome Awareness Day.
SUMMARY: Recognizes February 15, 2026, as Angelman Syndrome Awareness Day. Specifically, this resolution makes the following legislative findings:
- Angelman syndrome is a rare neurogenetic disorder that occurs in 1 in 15,000 live births and affects approximately 500,000 individuals worldwide. It is caused by a loss of function of the UBE3A gene in chromosome 15 derived from the mother, and a gene that is needed to develop and control speech and movement.
- Individuals with Angelman syndrome begin experiencing developmental delays starting from 6 and 12 months of age, inclusive, and these developmental delays are often the first signs of Angelman syndrome. In addition to delayed development, Angelman syndrome causes problems with speech and balance, mental disability, and sometimes seizures.
- Angelman syndrome shares symptoms and characteristics with other disorders, including autism, cerebral palsy, and Prader-Willi syndrome.
- Individuals with Angelman syndrome have an overall happy and excitable demeanor, and they smile and laugh often.
- There is currently no cure for Angelman syndrome, but organizations such as the Angelman Syndrome Foundation note that with further research, there may be a cure in the future.
- Organizations worldwide recognize February 15 as International Angelman Day to raise awareness about Angelman syndrome.
FISCAL EFFECT: This resolution is keyed non-fiscal by Legislative Counsel.
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Michael Erke / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):